The stock of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) increased by $0.29 on Friday to finish at $37.53, up 0.78 percent. The last five days have seen an average of 889,200 shares of common stock traded. 18 times new highs were reached in the current year, with a gain of $5.69. The average number of shares traded over the last 20 days was 1,281,765, while the average volume over the last 50 days totaled 1,500,636.
XRAY stock dropped -7.70% since last month. On 08/18/23, the company’s shares reached a one-month low of $36.84. The stock touched a high of $43.24 on 05/03/23, after rallying from a low of $26.48 in 52 weeks. The price of XRAY stock has risen by 17.87% or $5.69 this year, reaching a new high 18 times. Still, the stock price is down -13.21% from the 52-week high.
Insider Transactions
XRAY stock investors should be aware that DENTSPLY SIRONA Inc. (XRAY) stock had its last reported insider trading activity 118 days ago on May 02. On May 02, Director BRANDT ERIC sold 6,200 shares at $42.17 each. This transaction resulted in the insider making $261,454. On Mar 07, Staehler Cord Friedrich sold 4,000 shares at a price of US$39.33. After the transaction, the insider now owns 97,693 shares. Director LUCIER GREGORY T had earlier bought 6,000 shares on Nov 15 for $31.45 a share. The transaction was completed for $188,700.
Valuation Metrics
Beta for the stock is 0.98. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 2.00, the price-to-book (PB) ratio of 2.15, and the price-to-cash flow ratio of 39.82.
Company paid $0.14 per share in dividends, remained unchanged from $0.14 last year.
Financial Health
For the three months ended June 29, DENTSPLY SIRONA Inc.’s quick ratio was 1.00, while its current ratio was 1.50, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.50, and the total debt to equity ratio is 0.57. As far as profitability goes, gross margin for the trailing twelve months is 53.30% percent. DENTSPLY SIRONA Inc.’s EBITDA margin for the year ended June 29 was 17.72%, whereas its operating margin stood at -27.40% for the same period. Based on annual data, it had gross profit of $2.13 billion and revenue of $3.92 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. XRAY’s return on assets (ROA) during the last 12 months has been -13.40%. There was a -14.50% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -27.80%.
Earnings Surprise
According to DENTSPLY SIRONA Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $1.03 billion, while revenues rose by 0.49% to $978.0 million. It was predicted that DENTSPLY SIRONA Inc.’s quarterly earnings would be $0.51, but it ended up being $0.43, beating the consensus by 18.60%. EBITDA was $166.0 million for the quarter. At the end of DENTSPLY SIRONA Inc.’s most recent quarter ended June 29, its liabilities totaled 3.95 billion, while its total debt was $2.28 billion. Equity owned by shareholders amounts to $211.72 million.
Technical Picture
Here’s a quick look at DENTSPLY SIRONA Inc.’s (XRAY) price momentum from a technical perspective. As of 25 August, the RSI 9-day stood at 37.28%, suggesting the stock is Neutral, with a 14.02% historical volatility rate.
The stochastic %K and %D were 23.69% and 21.96% respectively, while the average true range (ATR) was 0.64. Based on the 14-day stochastic reading of 25.94%, the RSI (14) reading is 37.78%. On the 9-day MACD Oscillator, the stock is at 0.07, and the 14-day reading is at -0.38.
Analyst Ratings
In its most recent analyst report, William Blair raised its rating on DENTSPLY SIRONA Inc. (NASDAQ: XRAY) to a Mkt perform. Prior to this, analysts firm rated the stock as an Underperform. Analysts have assigned DENTSPLY SIRONA Inc. (XRAY) an Overweight rating. XRAY is a stock that is recommended for selling by 0 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is XRAY’s price target for the next 12 months?
The current consensus forecast for the stock is between $40.00 and $51.00, with a median target price of $44.00. In analyzing these forecasts, the average price target given by analysts for DENTSPLY SIRONA Inc. (XRAY) is $44.30.
